期刊文献+

结核杆菌特异性抗原对结核病诊断价值研究 被引量:4

Value of detection of ESAT-6,CFP10 and 38KD of Mycobacterium tuberculosis antigen in diagnosis of tuberculosis
原文传递
导出
摘要 目的从人血清提取结核杆菌早期分泌性抗原靶6、培养滤液蛋白、结核杆菌分泌蛋白38KD进行标测,探讨结核病诊断新方法。方法选择我院2007年1月~2008年1月间住院肺结核病人和健康查体者,应用结核分枝杆菌相关性抗原ESAT-6、CFP10、38KD检测试剂盒测定血清结核菌抗原水平,同时对所有入选者均行结核菌培养。结果活动性肺结核患者血清中检测到结核分枝杆菌特异性抗原ESAT-6、CFP10、38KD的阳性率高,与健康对照组有统计学差异(P〈0.005);结核分枝杆菌抗原可区分结核感染和非感染,与结核菌素试验比较有显著的统计学差异(P〈0.001)。结论血清结核杆菌特异性抗原能够作为诊断结核病的依据,对鉴别活动性肺结核、非活动性肺结核、非结核病具有重要的价值。 Objective To seek new methods for detection of Mycobacterium tuberculosis by detection of ESAT-6, CFP10 and 38KD with ELISA. Methods The antigen of ESAT-6,CFP10 and 38KD secreted by Mycobacterium tuberculosis in 398 patients and 200 healthy controls were detected from January 2007 to January 2008 by ELISA doubleantibody sandwich method and Mycobacterium tuberculosis was cultured in all the selected simultaneously. Results 1. ESAT-6,CFP10,and 38KD secreted by Myeobacterium tuberculosis were detected in the active pulmonary tuberculosis patients and Mycobacterium tuberculosis specific antigen was not detected in the healthy controls (P〈0.005).2. Mycobacterium tuberculosis specific antigen can distinguish tuberculosis infection from non- tuberculosis infection; showing significant difference comparing with tuberculin testing in statistics (P〈0.001). Conclusion Mycobacterium tuberculosis specific antigen can distinguish tuberculosis infection from non- tuberculosis and it is of important value in diagnosis of Mmycobacterium tuberculosis infection.
出处 《中国热带医学》 CAS 2009年第11期2085-2086,共2页 China Tropical Medicine
关键词 肺结核 结核杆菌 相关性抗原 早期分泌抗原靶6 培养滤液蛋白10 Pulmonary tuberculosis Mycobacterium tuberculosis Specific antigen 6kDa early secretion antigenic target Culture filtrate protein 10
  • 相关文献

参考文献11

二级参考文献37

  • 1全国结核病流行病学抽样调查领导小组.1979年全国结核病流行病学抽样调查综合报告[J].中国防痨通讯,1982,2:3-6.
  • 2[1]Murray CJL,Lope AD.Global mortality,disability and the contribution of risk factors: global Burden of disease study.Lancet,1997,349(9063): 1436~1442.
  • 3[2]Dye C,Scheele S,Dolin P,et al.Consensus statement global burden of tuberculosis: estimated incidence,prevalence and mortality by country.WHO global surveillance monitoring project.JAMA,1999,282(7): 677~686.
  • 4[3]World Health Organization.World health report 1999.http://www.who.int/whr/1999/en/report.htm/1999.
  • 5[4]Cole ST,Brosch R,Parkhill J,et al.Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence.Nature,1998,393(6685):537~544.
  • 6[5]Cox JS,Chen B,McNell M,et al.Complex lipid determines tissue-specific replication of mycobacterium in mice.Nature,1999,402(6757):79~83.
  • 7[6]Mariani F,Cappelii G,Riccardi G,et al.Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage.Gene,2000,252(2):281~291.
  • 8[7]Telenti A,Iseman M.Drug-resistant tuberculosis.Drug,2000,59(2):171~179.
  • 9[8]Raynaud C,Laneelle MA,Senaratne RH,et al.Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyranamidase activity.Microbiology,1999,145(pt6):1359~1367.
  • 10[9]Lowie DB,Tascon RE,Bonato VLD,et al.Therapy of tuberculosis in mice by DNA vaccination.Nature,1999,400(6741):269~271.

共引文献3988

同被引文献31

  • 1马均,朱莉贞,潘毓萱.结核病[M].北京:人民卫生出版社,2006:285-293.
  • 2Passalent L, Khan K, Richardson R, et al. Detecting latent tuberculosis infection in hemodialysis patients: a head-to- head comparison of the T-SPOT. TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol, 2007,2 : 68-73.
  • 3Meier T, Eulenbruch HP, Wrighton-Smith P, et al. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis, 2005,24 : 529-536.
  • 4Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis,1993,17:968-975.
  • 5La[vani A. Spotting latent infection: the path to better tuberculosis control. Thorax, 2003,58 :916-918.
  • 6Chee CB, Gan SH, Khinmar KW, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol, 2008, 46,1935-1940.
  • 7Kang YA, Lee HW, Hwang SS,et al. Usefulness of whole- blood interferon-gamma assay and interferon-gamma enzyme- linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest, 2007,132:959-965.
  • 8Kim SH, Choi SJ, Kim HB et al. Diagnostic usefulness of a T-cell based assay for cxtrapulmonary tuberculosis. Arch Intern Med, 2007,167 : 2255-2259.
  • 9Jin XJ, Kim JM, K PCR kit analysis in im HK, et al. Histopathology and TB- differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World ] Gastroenterol, 2010,16 : 2496-2503.
  • 10Lee JN, Ryu DY, Park SH, et al. The usefulness of in vitro interferon-gamma assay for differential diagnosis between intestinal tuberculosis and Crohns disease. Korean J Gastroenterol, 2010,55:376-383.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部